Το συγκεκριμένο εκχύλισμα φαίνεται βάσει ερευνών να έχει οφέλη στην προσπάθεια αντιμετώπισης του προβλήματός μας επιρρεάζοντας πολλούς παράγοντες.
Οι έρευνες
1)
https://www.ncbi.nlm.nih.gov/pubmed/24375856
"Immunohistochemical analysis showed that expression of
VEGF was significantly up-regulated by Rg3 in a dose-dependent manner in human DP cells and in mouse hair follicles. In addition, the
CD8 and CD34 were also up-regulated by Rg3 in the mouse hair follicles. It may be concluded that Rg3 might increase hair growth through stimulation of hair follicle stem cells and it has the potential to be used in hair growth products"
2)
https://www.ncbi.nlm.nih.gov/pubmed/25396716
"Both RGE and ginsenoside-Rb1 enhanced the proliferation of hair matrix keratinocytes. hDPCs treated with RGE or ginsenoside-Rb1 exhibited substantial cell proliferation and the associated phosphorylation of ERK and AKT. Moreover, RGE, ginsenoside-Rb1, and ginsenoside-Rg3 abrogated the DHT-induced suppression of hair matrix keratinocyte proliferation and the DHT-induced upregulation of the mRNA expression of androgen receptor in hDPCs. Murine experiments revealed that the subcutaneous
injection of 3% RGE resulted in more rapid hair growth than the negative control. In conclusion,
RGE and its ginsenosides may enhance hDPC proliferation, activate ERK and AKT signaling pathways in hDPCs, upregulate hair matrix keratinocyte proliferation, and inhibit the DHT-induced androgen receptor transcription. These results suggest that red ginseng may promote hair growth in humans."
[hDPCs=human dermal papilla cells]
3)
https://www.ncbi.nlm.nih.gov/pubmed/24789999
"The cell-based 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay showed that the
proliferation rates of DHT-treated human hair dermal papilla cells (HHDPCs) and HaCaTs increased by 48% in the ginsenoside F2-treated group and by 12% in the finasteride-treated group. Western blot analysis showed that
ginsenoside F2 decreased expression of TGF-β2 related factors involved in hair loss. The present study suggested a hair loss related pathway by changing SCAP related apoptosis pathway, which has been known to control cholesterol metabolism.
SCAP, sterol regulatory element-binding protein (SREBP) and caspase-12 expression in the ginsenoside F2-treated group were decreased compared to the DHT and finasteride-treated group."
"Hair growth rate, density, thickness measurements and tissue histotological analysis in these groups suggested that
ginsenoside F2 suppressed hair cell apoptosis and premature entry to catagen more effectively than finasteride.Our results indicated that
ginsenoside F2 decreased the expression of TGF-β2 and SCAP proteins, which have been suggested to be involved in apoptosis and entry into catagen. This study provides evidence those factors in the SCAP pathway could be targets for hair loss prevention drugs."